Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
May 30, 2024 07:00 ET
|
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
Proxygen Announces Formation of Scientific Advisory Board
November 15, 2023 07:00 ET
|
Proxygen
SAB Comprised of Pioneers in the Field of Protein Degradation, Including Unique Expertise in Roles of Ubiquitin Biology and Translational Medicine Track Records of Founding Biopharma Companies and...
Proxygen Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Molecular Glue Degraders
April 05, 2023 07:00 ET
|
Proxygen
VIENNA, Austria, April 05, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, announced today a multi-year research collaboration and license...
Proxygen Announces Formation of Board of Directors
March 15, 2023 07:00 ET
|
Proxygen
VIENNA, Austria, March 15, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced the formation of the company’s board of...
Global Targeted Protein Degradation (TPD) Market Research Report 2022
April 11, 2022 04:18 ET
|
Research and Markets
Dublin, April 11, 2022 (GLOBE NEWSWIRE) -- The "Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: An Industry Landscape Analysis of Stakeholders, Technologies,...